Please use this identifier to cite or link to this item: https://doi.org/10.1177/11297298221095769
Title: The clinical journey and healthcare resources required for dialysis access of end-stage kidney disease patients during their first year of hemodialysis
Authors: Ho, Pei 
Binte Taufiq Chong Ah Hoo, Nur Nabila Farhana
Cheng, Yi Xin 
Meng, Lingyan 
Chai Min Shen, Darryl
Teo, Boon Wee 
Ma, Valerie
Hargreaves, Carol Anne 
Keywords: Science & Technology
Life Sciences & Biomedicine
Peripheral Vascular Disease
Cardiovascular System & Cardiology
Vascular access
hemodialysis
healthcare cost
healthcare resource
central venous catheter
ARTERIOVENOUS-FISTULA MATURATION
VASCULAR ACCESS
OUTCOMES
COMPLICATIONS
ULTRASOUND
RATES
TOOL
AVF
Issue Date: 11-May-2022
Publisher: SAGE PUBLICATIONS LTD
Citation: Ho, Pei, Binte Taufiq Chong Ah Hoo, Nur Nabila Farhana, Cheng, Yi Xin, Meng, Lingyan, Chai Min Shen, Darryl, Teo, Boon Wee, Ma, Valerie, Hargreaves, Carol Anne (2022-05-11). The clinical journey and healthcare resources required for dialysis access of end-stage kidney disease patients during their first year of hemodialysis. JOURNAL OF VASCULAR ACCESS. ScholarBank@NUS Repository. https://doi.org/10.1177/11297298221095769
Abstract: Background: Creation and maintenance of dialysis vascular access (VA) is a major component of healthcare resource utilization and cost for patients newly started on hemodialysis (HD). Different VA format arises due to patient acceptance of anticipatory care versus late preparation, and clinical characteristics. This study reviews the clinical journey and resource utilization required for different VA formats in the first year of HD. Method: Data of patients newly commenced on HD between July 2015 and June 2016 were reviewed. Patients were grouped by their VA format: (A) pre-emptive surgically created VA (SCVA), (B) tunneled central venous catheter (CVC) followed by SCVA creation, (C) long-term tunneled CVC only. Clinical events, number of investigations and procedures, hospital admissions, and incurred costs of the three groups were compared. Results: In the multivariable analysis, the cost incurred by the group A patients had no significant difference to that incurred in the group B patients (p = 0.08), while the cost of group C is significantly lower (p < 0.001). Both the 62.7% of group A with successful SCVA who avoided tunneled CVC usage, and those with a functionally matured SCVA in group B (66.1%), used fewer healthcare resources and incurred less cost for their access compared to those did not (p = 0.01, p = 0.02, respectively) during the first year of HD. Conclusion: With comparable cost, a pre-emptive approach enables avoidance of tunneled CVC. Tunneled CVC only access format incurred lower cost and is suitable for carefully selected patients. Successful maturation of SCVA greatly affects patients’ clinical journey and healthcare cost.
Source Title: JOURNAL OF VASCULAR ACCESS
URI: https://scholarbank.nus.edu.sg/handle/10635/229320
ISSN: 11297298
17246032
DOI: 10.1177/11297298221095769
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
The clinical journey and healthcare resources requirements associated to dialysis access (002).pdf1.55 MBAdobe PDF

OPEN

Post-printView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.